References
- KingmanSGlaucoma is second leading cause of blindness globallyBull World Health Organ2004821188788815640929
- QuigleyHABromanATThe number of people with glaucoma worldwide in 2010 and 2020Br J Ophthalmol200690326226716488940
- KaushikSPandavSSRamJNeuroprotection in glaucomaJ Postgrad Med20034919012865582
- ChangEEGoldbergJLGlaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancementOphthalmology2012119597998622349567
- DielemansIVingerlingJRWolfsRCWHofmanAGrobbeeDEde JongPTVMThe prevalence of primary open-angle glaucoma in a population-based study in the Netherlands: the Rotterdam studyOphthalmology199410111185118557800368
- LeskeMCWuSYHennisABESs Study GroupRisk factors for incident open-angle glaucoma: the Barbados eye studiesOphthalmology20081151859317629563
- BagnisAPapadiaMScottoRTraversoCECurrent and emerging medical therapies in the treatment of glaucomaExpert Opin Emerg Drugs201116229330721406029
- HeijlABengtssonBHymanLLeskeMCEarly Manifest Glaucoma Trial GroupNatural history of open-angle glaucomaOphthalmology2009116122271227619854514
- KolkoMPresent and new treatment strategies in the management of glaucomaOpen Ophthalmol J201598910026069521
- HigginbothamEJConsiderations in glaucoma therapy: fixed combinations versus their component medicationsClin Ophthalmol2010411920169043
- CassonRJChidlowGEbneterAWoodJPCrowstonJGoldbergITranslational neuroprotection research in glaucoma: a review of definitions and principlesClin Exp Ophthalmol2012404350357
- EmreEYükselNDuruksuGNeuroprotective effects of intravitreally transplanted adipose tissue and bone marrow–derived mesenchymal stem cells in an experimental ocular hypertension modelCytotherapy201517554355925618560
- SenaDFRamchandKLindsleyKNeuroprotection for treatment of glaucoma in adultsCochrane Database Syst Rev20102CD00653920166085
- O’NeillECMackeyDAConnellPPHewittAWDanesh-MeyerHVCrowstonJGThe optic nerve head in hereditary optic neuropathiesNat Rev Neurol20095527728719488085
- OsborneNNUgarteMChaoMNeuroprotection in relation to retinal ischemia and relevance to glaucomaSurv Ophthalmol199943S102S12810416754
- IzzottiABagnisASaccàSCThe role of oxidative stress in glaucomaMutat Res2006612210511416413223
- QuigleyHAMcKinnonSJZackDJRetrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in ratsInvestig Ophthalmol Vis Sci200041113460346611006239
- D’hondtCSrinivasSPVereeckeJHimpensBAdenosine opposes thrombin-induced inhibition of intercellular calcium wave in corneal endothelial cellsInvest Ophthalmol Vis Sci20074841518152717389480
- KuehnMHKimCYOstojicJRetinal synthesis and deposition of complement components induced by ocular hypertensionExp Eye Res200683362062816677633
- DreyerEBA proposed role for excitotoxicity in glaucomaJ Glaucoma19987162679493118
- MichaelisEKMolecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and agingProg Neurobiol19985443694159522394
- MasseySCRedburnDATransmitter circuits in the vertebrate retinaProg Neurobiol198728155962881324
- DkhissiOChanutEWasowiczMRetinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorderInvestig Ophthalmol Vis Sci19994099099410102297
- SongWHuangPZhangCNeuroprotective therapies for glaucomaDrug Des Devel Ther2015914691479
- DreyerEBZurakowskiDSchumerRAPodosSMLiptonSAElevated glutamate levels in the vitreous body of humans and monkeys with glaucomaArch Ophthalmol199611432993058600890
- BrooksDEGarciaGADreyerEBZurakowskiDFranco-BourlandREVitreous body glutamate concentration in dogs with glaucomaAm J Vet Res19975888648679256971
- OsborneNNRecent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandonedActa Ophthalmol200987445045419141144
- DyskenMWSanoMAsthanaSEffect of vitamin E and meman-tine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trialJAMA20143111334424381967
- GabeltBTRasmussenCATektasOYStructure/function studies and the effects of memantine in monkeys with experimental glaucomaInvestig Ophthalmol Vis Sci20125342368237622427549
- MayamaCCalcium channels and their blockers in intraocular pressure and glaucomaEur J Pharmacol20137399610524291107
- TakahashiKLamTTEdwardDPBuchiERTsoMOMProtective effects of flunarizine on ischemic injury in the rat retinaArch Ophthalmol199211068628701596236
- KosekiNAraieMTomidokoroAA placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressureOphthalmology2008115112049205718672290
- PooMNeurotrophins as synaptic modulatorsNat Rev Neurosci200121243211253356
- YanQWangJMathesonCRUrichJLGlial cell line – derived neurotrophic factor (GDNF) promotes the survival of axotomized retinal ganglion cells in adult rats: comparison to and combination with brain-derived neurotrophic factor (BDNF)J Neurobiol199938338239010022580
- KoM-LHuD-NRitchRSharmaSCChenC-FPatterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of ratsNeurosci Lett2001305213914211376903
- FuQLLiXYipHKCombined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucomaNeuroscience2009162237538219422885
- Parrilla-ReverterGAgudoMSobrado-CalvoPSalinas-NavarroMVillegas-PérezMPVidal-SanzMEffects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo studyExp Eye Res2009891324119268467
- JiJZElyamanWYipHKCNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathwayEur J Neurosci200419226527214725620
- ChengLSapiehaPKittlerováPHauswirthWWDi PoloATrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivoJ Neurosci200222103977398612019317
- Checa-CasalenguaPJiangCBravo-OsunaIRetinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedureJ Control Release201115619210021704662
- ZhangKHopkinsJJHeierJSCiliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degenerationProc Natl Acad Sci U S A2011108156241624521444807
- LambiaseAAloeLCentofantiMExperimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucomaProc Natl Acad Sci U S A200910632134691347419805021
- MiyazakiMIkedaYYonemitsuYPigment epithelium-derived factor gene therapy targeting retinal ganglion cell injuries: neuroprotection against loss of function in two animal modelsHum Gene Ther201022555956521175295
- AkmanACetinkayaAAkovaYAErtanAComparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol – dorzolamide combinationEye200519214515115184958
- Levkovitch-VerbinHHarris-CerrutiCGronerYWheelerLASchwartzMYolesERGC death in mice after optic nerve crush injury: oxidative stress and neuroprotectionInvestig Ophthalmol Vis Sci200041134169417411095611
- WheelerLAGilDWWoldeMussieERole of alpha-2 adrenergic receptors in neuroprotection and glaucomaSurv Ophthalmol200145S290S29411377451
- SembaKNamekataKKimuraAHaradaCMitamuraYHaradaTBrimonidine prevents neurodegeneration in a mouse model of normal tension glaucomaCell Death Dis201457e134125032864
- KrupinTLiebmannJMGreenfieldDSRitchRGardinerSA randomized trial of brimonidine versus timolol in preserving visual function: results from the low-pressure glaucoma treatment studyAm J Ophthalmol2011151467168121257146
- De MoraesCGLiebmannJMGreenfieldDSGardinerSKRitchRKrupinTRisk factors for visual field progression in the low-pressure glaucoma treatment studyAm J Ophthalmol2012154470271122835512
- KolomeyerAMZarbinMATrophic factors in the pathogenesis and therapy for retinal degenerative diseasesSurv Ophthalmol201459213416524417953
- CuencaNFernández-SánchezLCampelloLCellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseasesProg Retin Eye Res20144315925016980
- IzzottiASaccàSCCartigliaCDe FloraSOxidative deoxyribo-nucleic acid damage in the eyes of glaucoma patientsAm J Med2003114863864612798451
- SaccàSCPascottoACamicionePCaprisPIzzottiAOxidative DNA damage in human trabecular meshwork and its correlation with intraocular pressure and visual field in primary open angle glaucomaArch Ophthalmol200512345846315824217
- NeufeldAHPharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucomaBrain Res Bull200462645545915036557
- BirichTVBirichTAMarchenkoLNRemizonovaDNFedylovASVitamin E in the complex treatment of patients with primary glaucomaVestn Oftalmol1985102210133716072
- CelliniMCaramazzaNMangiaficoPPossatiGLCaramazzaRFatty acid use in glaucomatous optic neuropathy treatmentActa Ophthalmol Scand199876S2274142
- BuschiniEFeaAMLaviaCARecent developments in the management of dry age-related macular degenerationClin Ophthalmol2015956357425878491
- KoM-LPengP-HHsuS-YChenC-FDietary deficiency of vitamin E aggravates retinal ganglion cell death in experimental glaucoma of ratsCurr Eye Res201035984284920795867
- HsuKHde la JaraPLAriyavidanaARelease of betaine and dexpanthenol from vitamin E modified silicone-hydrogel contact lensesCurr Eye Res201440326727324833321
- HsuK-HCarbiaBEPlummerCChauhanADual drug delivery from vitamin E loaded contact lenses for glaucoma therapyEur J Pharm Biopharm20159431232126071799
- DeFeudisFVGinkgo Biloba Extract (EGb 761): Pharmacological Activities and Clinical ApplicationsParisElsevier1991
- Detry-MorelMProspects in the medical treatment of glaucomatous neuropathy. Basics of neuroprotectionJ Fr Ophtalmol199922112210221206
- Cybulska-HeinrichAKMozaffariehMFlammerJGinkgo biloba: an adjuvant therapy for progressive normal and high tension glaucomaMol Vis20121839022355250
- BealMFCoenzyme Q10 administration and its potential for treatment of neurodegenerative diseasesBiofactors199992–426126610416039
- NucciCTartaglioneRCerulliARetinal damage caused by high intraocular pressure – induced transient ischemia is prevented by coenzyme Q10 in ratInt Rev Neurobiol20078239740617678974
- NakajimaYInokuchiYNishiMShimazawaMOtsuboKHaraHCoenzyme Q 10 protects retinal cells against oxidative stress in vitro and in vivoBrain Res2008122622623318598676
- ParisiVCentofantiMGandolfiSEffects of coenzyme Q10 in conjunction with vitamin E on retinal-evoked and cortical-evoked responses in patients with open-angle glaucomaJ Glaucoma201423639140425079307
- TezelGImmune regulation toward immunomodulation for neuroprotection in glaucomaCurr Opin Pharmacol2013131233123084793
- TezelGThe immune response in glaucoma: a perspective on the roles of oxidative stressExp Eye Res201193217818620709058
- WaxMBTezelGImmunoregulation of retinal ganglion cell fate in glaucomaExp Eye Res200988482583019233171
- TezelGThe role of glia, mitochondria, and the immune system in glaucomaInvest Ophthalmol Vis Sci20095031001101219244206
- NaskarRWissingMThanosSDetection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucomaInvestig Ophthalmol Vis Sci20024392962296812202516
- TezelGLiLYPatilRVWaxMBTNF- and TNF-receptor-1 in the retina of normal and glaucomatous eyesInvestig Ophthalmol Vis Sci20014281787179411431443
- McKinnonSJThe cell and molecular biology of glaucoma: common neurodegenerative pathways and relevance to glaucomaInvest Ophthalmol Vis Sci20125352485248722562847
- WaxMBTezelGYangJInduced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fasligandJ Neurosci20082846120851209619005073
- HongSParkKKimCYSeongGJAgmatine inhibits hypoxia-induced TNF-alpha release from cultured retinal ganglion cellsBiocell200832220120518825914
- HongSKimCYLeeWSShimJYeomHYSeongGJOcular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat modelExp Eye Res20109019710319782071
- RohMZhangYMurakamiYEtanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucomaPLoS One201277e4006522802951
- BringmannAGroscheAPannickeTReichenbachAGABA and glutamate uptake and metabolism in retinal glial (Müller) cellsFront Endocrinol2013448
- WangLCioffiGACullGDongJFortuneBImmunohistologic evidence for retinal glial cell changes in human glaucomaInvest Ophthalmol Vis Sci20024341088109411923250
- NeufeldAHMicroglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucomaArch Ophthalmol199911781050105610448748
- QuigleyHANickellsRWKerriganLAPeaseMEThibaultDJZackDJRetinal ganglion cell death in experimental glaucoma and after axotomy occurs byInvest Ophthalmol1995364774786
- CordeiroMFGuoLCoxonKMImaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivoCell Death Dis201011e321364622
- McKinnonSJLehmanDMTahzibNGBaculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma modelMol Ther20025678078712027563
- MorrisonSJKimbleJAsymmetric and symmetric stem-cell divisions in development and cancerNature200644170971068107416810241
- JohnsonTVBullNDMartinKRStem cell therapy for glaucoma: possibilities and practicalitiesExpert Rev Ophthalmol20116216517421686079
- BullNDMartinKRUsing stem cells to mend the retina in ocular diseaseRegen Med20094685586419903004
- LitonPBChallaPStinnettSLunaCEpsteinDLGonzalezPCellular senescence in the glaucomatous outflow pathwayExp Gerontol200540874574816051457
- DuYRohDSMannMMFunderburghMLFunderburghJLSchumanJSMultipotent stem cells from trabecular meshwork become phagocytic TM cellsInvest Ophthalmol Vis Sci20125331566157522297497
- DuYYunHYangESchumanJSStem cells from trabecular mesh-work home to TM tissue in vivoInvestig Ophthalmol Vis Sci20135421450145923341019
- Manuguerra-GagnéRBoulosPRAmmarATransplantation of mesenchymal stem cells promotes tissue regeneration in a glaucoma model through laser-induced paracrine factor secretion and progenitor cell recruitmentStem Cells20133161136114823495088
- MeyerJSKatzMLMaruniakJAKirkMDEmbryonic stem cell-derived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptorsStem Cells200624227428316123383
- VuglerALawrenceJWalshJEmbryonic stem cells and retinal repairMech Dev20071241180782917881192
- ChenMChenQSunXGeneration of retinal ganglion – like cells from reprogrammed mouse fibroblastsInvest Ophthalmol Vis Sci201051115970597820484577
- JagathaBDivyaMSSanalkumarRIn vitro differentiation of retinal ganglion-like cells from embryonic stem cell derived neural progenitorsBiochem Biophys Res Commun2009380223023519167364
- BullNDJohnsonTVMartinKRÃStem cells for neuroprotection in glaucomaProg Brain Res20081730851151918929131
- SadanOShemeshNCohenYMelamedEOffenDAdult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseasesIsr Med Assoc J200911420120419603590
- GuoLDavisBNizariSDirect optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivoCell Death Dis2014510e146025321467
- SadanOBahat-StromzaMBarhumYProtective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson diseaseStem Cells Dev20091881179119019243240
- Levkovitch-VerbinHSadanOVanderSIntravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transectionInvest Ophthalmol Vis Sci201051126394640020926814
- FlachsbarthKKruszewskiKJungGNeural stem cell-based intraocular administration of ciliary neurotrophic factor attenuates the loss of axotomized ganglion cells in adult miceInvest Ophthalmol Vis Sci201455117029703925270193
- SchwartzMYolesENeuroprotection: a new treatment modality for glaucoma?Curr Opin Ophthalmol200011210711110848215
- MedeirosFAAlencarLMZangwillLMSamplePAWeinrebRNThe relationship between intraocular pressure and progressive retinal nerve fiber layer loss in glaucomaOphthalmology200911661125113319376584
- HarwerthRSCarter-DawsonLSmithELBarnesGHoltWFCrawfordMLJNeural losses correlated with visual losses in clinical perimetryInvest Ophthalmol Vis Sci20044593152316015326134
- Kerrigan-BaumrindLAQuigleyHAPeaseMEKerriganDFMitchellRSNumber of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same personsInvest Ophthalmol Vis Sci200041374174810711689
- MedeirosFALisboaRWeinrebRNLiebmannJMGirkinCZangwillLMRetinal ganglion cell count estimates associated with early development of visual field defects in glaucomaOphthalmology2013120473674423246120
- BusselIIWollsteinGSchumanJSOCT for glaucoma diagnosis, screening and detection of glaucoma progressionBr J Ophthalmol201398suppl 2ii15ii1924357497
- El ChehabHDelbarreMMaréchalMNew neuroretinal rim analysis with spectral domain optical coherence tomography, spectralis (Heidelberg Engineering, Germany). Preliminary studyJ Fr Ophtalmol2015381465225575418
- FriedlanderRMApoptosis and caspases in neurodegenerative diseasesN Engl J Med2003348141365137512672865
- BizrahMDakinSCGuoLA semi-automated technique for labeling and counting of apoptosing retinal cellsBMC Bioinformatics201415116924902592
- van EngelandMNielandLJRamaekersFCSchutteBReutelingspergerCPAnnexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposureCytometry1998311199450519
- CarrollADMoyenCVan KesterenPTookeFBatteyNHBrownleeCCa2+, annexins, and GTP modulate exocytosis from maize root cap protoplastsPlant Cell1998108126712769707528
- MeersPMealyTCalcium-dependent annexin V binding to phospholipids: stoichiometry, specificity, and the role of negative chargeBiochemistry1993324311711117218218240
- BlankenbergFGKatsikisPDTaitJFIn vivo detection and imaging of phosphatidylserine expression during programmed cell deathProc Natl Acad Sci U S A19989511634963549600968
- FlotatsACarrióINon-invasive in vivo imaging of myocardial apoptosis and necrosisEur J Nucl Med Mol Imaging200330461563012638039
- YangDJAzhdariniaAWuPIn vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin VCancer Biother Radiopharm2001161738311279800
- HorisbergerKErbenPStröbelPAnnexin and survivin in locally advanced rectal cancer: indicators of resistance to preoperative chemoradiotherapy?Onkologie2010338–943944420838059
- CordeiroMFGuoLLuongVReal-time imaging of single nerve cell apoptosis in retinal neurodegenerationProc Natl Acad Sci U S A200410136133521335615340151
- CordeiroMFMigdalCBloomPFitzkeFWMossSEImaging apoptosis in the eyeEye (Lond)201125554555321436846
- GuoLMossSEAlexanderRAAliRRFitzkeFWCordeiroMFRetinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrixInvest Ophthalmol Vis Sci200546117515623771
- GuoLSaltTEMaassAAssessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivoInvest Ophthalmol Vis Sci200647262616431960
- GuoLSaltTELuongVTargeting amyloidbeta in glaucoma treatmentProc Natl Acad Sci U S A200710433134441344917684098
- Schmitz-ValckenbergSGuoLMaassAReal-time in vivo imaging of retinal cell apoptosis after laser exposureInvest Ophthalmol Vis Sci2008496277318281610
- Prevention of blindness and visual impairment: Priority eye diseasesWorld Health Organization Available from: http://www.who.int/blindness/causes/priority/en/index9.htmlAccessed October 16, 2015